GENinCode PLC

LSE:GENI (UK)  
£ 0.08 (0%) May 24
At Loss
P/B:
1.65
Market Cap:
£ 14.60M ($ 18.49M)
Enterprise V:
£ 9.72M ($ 12.30M)
Volume:
19.05K
Avg Vol (2M):
527.60K
Also Trade In:
Volume:
19.05K
At Loss
Avg Vol (2M):
527.60K

Business Description

Description
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment being sale of kits and provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain and United Kingdom.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 16.22
Equity-to-Asset 0.67
Debt-to-Equity 0.07
Debt-to-EBITDA -0.05
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.74
Distress
Grey
Safe
Beneish M-Score -2.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 42.17
9-Day RSI 48.82
14-Day RSI 52.49
6-1 Month Momentum % 14.81
12-1 Month Momentum % -41.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.92
Quick Ratio 5.85
Cash Ratio 5.16
Days Inventory 17.57
Days Sales Outstanding 106.71
Days Payable 422.99

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-06-03)

LSE:GENI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

GENinCode PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 1.716
EPS (TTM) (£) -0.067
Beta 0
Volatility % 31.59
14-Day RSI 52.49
14-Day ATR (£) 0.005839
20-Day SMA (£) 0.08175
12-1 Month Momentum % -41.51
52-Week Range (£) 0.0334 - 0.14
Shares Outstanding (Mil) 176.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GENinCode PLC Filings

Filing Date Document Date Form
No Filing Data

GENinCode PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

GENinCode PLC Frequently Asked Questions

What is GENinCode PLC(LSE:GENI)'s stock price today?
The current price of LSE:GENI is £0.08. The 52 week high of LSE:GENI is £0.14 and 52 week low is £0.03.
When is next earnings date of GENinCode PLC(LSE:GENI)?
The next earnings date of GENinCode PLC(LSE:GENI) is 2024-06-03.
Does GENinCode PLC(LSE:GENI) pay dividends? If so, how much?
GENinCode PLC(LSE:GENI) does not pay dividend.

Press Release

Subject Date
No Press Release